YIH
OSCR icon

Y-Intercept (HK)’s Oscar Health OSCR Stock Holding History

Y-Intercept (HK)’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-253,956
Closed -$4.81M – 1883
2025
Q3 		$4.81M Buy
253,956
+19,803
+8% +$326K 0.12% 220
2025
Q2 		$5.02M Buy
+234,153
New +$3.48M 0.12% 218
2024
Q4 		– Sell
-130,338
Closed -$2.76M – 1528
2024
Q3 		$2.76M Buy
+130,338
New +$2.35M 0.17% 135
2024
Q2 		– Sell
-50,729
Closed -$754K – 1784
2024
Q1 		$754K Buy
50,729
+28,699
+130% +$393K 0.06% 507
2023
Q4 		$202K Buy
+22,030
New +$152K 0.02% 1005
2022
Q2 		– Sell
-11,850
Closed -$118K – 1108
2022
Q1 		$118K Buy
+11,850
New +$88.2K 0.03% 664

Other funds holding OSCR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Y-Intercept (HK)'s OSCR Position: Q4 2025 in Review

Y-Intercept (HK) sold out of Oscar Health (OSCR) in Q4 2025, closing a stake of 253,956 shares — an estimated $4.81M sold.

Y-Intercept (HK) first reported a position in OSCR in Q1 2022 and held it in 6 quarters. The position peaked at $5.02M in Q2 2025. 343 funds tracked by Wall St. Rank hold OSCR as of Q4 2025.

  • Y-Intercept (HK) reported no remaining Oscar Health position as of Q4 2025 after selling out during the quarter.
  • Y-Intercept (HK) sold 253,956 Oscar Health shares in Q4 2025, an estimated $4.81M.
  • Y-Intercept (HK) first reported a position in Oscar Health in Q1 2022 and held it in 6 quarters.
  • Y-Intercept (HK)'s Oscar Health position peaked at $5.02M in Q2 2025.
  • 343 funds tracked by Wall St. Rank held Oscar Health as of Q4 2025.

Based on Y-Intercept (HK)'s 13F filing for Q4 2025, filed 13 Feb 2026.